| NASDAQ (usa) |
 |
6715.56 | -12.11 | -0.18% |
| FTSE 100 (london) |
|
7487.96 | -5.12 | -0.07% |
| DAX (german) |
 |
13465.51 | 235.94 | 1.78% |
| NIKKEI 225 (japan) |
|
22420.08 | 408.47 | 1.86% |
| Hang - Seng (hong kong) |
|
28594.06 | 348.52 | 1.23% |
| NIFTY - 50 (india) | ||||
| Straits Times (singapore) |
|
3391.61 | 17.53 | 0.52% |
| KOSPI (korea) |
|
2556.47 | 33.04 | 1.31% |
| All Ordinaries (australia) |
|
6005.30 | 28.90 | 0.48% |
| BOVESPA (brazil) |
|
74092.76 | -215.73 | -0.29% |
scPharmaceuticals Inc (NASDAQ: SCPH)
SCPH Technical Analysis
5
| As on 9th Jun 2023 SCPH STOCK Price closed @ 9.97 and we RECOMMEND Strong Buy for LONG-TERM with Stoploss of 5.19 & Strong Buy for SHORT-TERM with Stoploss of 4.80 we also expect STOCK to react on Following IMPORTANT LEVELS. |
SCPHSTOCK Price
| Open | 9.91 | Change | Price | % |
| High | 10.26 | 1 Day | 0.06 | 0.61 |
| Low | 9.76 | 1 Week | -0.65 | -6.12 |
| Close | 9.97 | 1 Month | 0.48 | 5.06 |
| Volume | 387808 | 1 Year | 4.84 | 94.35 |
| 52 Week High 11.74 | 52 Week Low 3.90 | ||||
NASDAQ USA Most Active Stocks
| TSLA | 244.40 | 4.06% |
| TTOO | 0.07 | -12.50% |
| SOFI | 8.18 | 0.74% |
| FFIE | 0.33 | 6.45% |
| PONO | 1.72 | 2.38% |
| AMD | 124.92 | 3.20% |
| IDEX | 0.06 | 0.00% |
| NKLA | 0.70 | 14.75% |
| AMZN | 123.43 | -0.66% |
| AAPL | 180.96 | 0.22% |
NASDAQ USA Top Gainers Stocks
NASDAQ USA Top Losers Stocks
| SCPH Daily Charts |
SCPH Intraday Charts |
Whats New @ Bazaartrend |
SCPH Free Analysis |
|
|
SCPH Important Levels Intraday
| RESISTANCE | 10.93 |
| RESISTANCE | 10.62 |
| RESISTANCE | 10.43 |
| RESISTANCE | 10.24 |
| SUPPORT | 9.70 |
| SUPPORT | 9.51 |
| SUPPORT | 9.32 |
| SUPPORT | 9.01 |
SCPH Forecast May 2024
| 4th UP Forecast | 13.71 |
| 3rd UP Forecast | 12.51 |
| 2nd UP Forecast | 11.77 |
| 1st UP Forecast | 11.03 |
| 1st DOWN Forecast | 8.91 |
| 2nd DOWN Forecast | 8.17 |
| 3rd DOWN Forecast | 7.43 |
| 4th DOWN Forecast | 6.23 |
SCPH Weekly Forecast
| 4th UP Forecast | 11.59 |
| 3rd UP Forecast | 11.07 |
| 2nd UP Forecast | 10.75 |
| 1st UP Forecast | 10.43 |
| 1st DOWN Forecast | 9.51 |
| 2nd DOWN Forecast | 9.19 |
| 3rd DOWN Forecast | 8.87 |
| 4th DOWN Forecast | 8.35 |
SCPH Forecast2024
| 4th UP Forecast | 27.45 |
| 3rd UP Forecast | 21.84 |
| 2nd UP Forecast | 18.38 |
| 1st UP Forecast | 14.91 |
| 1st DOWN Forecast | 5.03 |
| 2nd DOWN Forecast | 1.56 |
| 3rd DOWN Forecast | -1.9 |
| 4th DOWN Forecast | -7.51 |
scPharmaceuticals Inc ( NASDAQ USA Symbol : SCPH )
Sector : Healthcare And Other Stocks in Same Sector
Sector : Healthcare And Other Stocks in Same Sector
SCPH Business Profile
scPharmaceuticals Inc., a pharmaceutical company, engages in the development and commercialization of various pharmaceutical products. The company's lead product candidate is FUROSCIX that consists of proprietary buffered formulation of furosemide, which is delivered through the SmartDose drug delivery system for treatment of congestion in decompensated heart failure patients. Its product pipeline also includes scCeftriaxone, an antibiotic to treat infections caused by gram-positive and gram-negative organisms; and scCarbapenem program, an antibiotic for treating infections caused by gram-negative organisms. The company has a development agreement with West Pharmaceutical Services, Inc. to incorporate SmartDose drug delivery system with Furoscix. scPharmaceuticals Inc. was incorporated in 2013 and is headquartered in Burlington, Massachusetts. Address: 2400 District Avenue, Burlington, MA, United States, 01803
© 2005-2023 BazaarTrend.com All rights reserved.
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service